Kirihara, Japan

Hiroyasu Takahashi



 

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 54(Granted Patents)


Location History:

  • Miyagi, JP (2020)
  • Kirihara, JP (2017 - 2022)

Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Hiroyasu Takahashi: Innovator in Pharmaceutical Chemistry

Introduction

Hiroyasu Takahashi is a prominent inventor based in Kirihara, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the body. With a total of eight patents to his name, Takahashi's work has the potential to impact various medical conditions.

Latest Patents

Takahashi's latest patents include a urea derivative or pharmacologically acceptable salt thereof, which exhibits a formyl peptide receptor like 1 (FPRL1) agonist effect. This invention relates to a compound represented by a specific general formula, which is useful in treating, preventing, or suppressing a range of inflammatory diseases, chronic airway diseases, cancers, and other serious health conditions. The pharmaceutical composition containing this compound is designed to enhance therapeutic outcomes for patients suffering from various ailments.

Career Highlights

Throughout his career, Takahashi has worked with notable companies, including Kyorin Pharmaceutical Co., Ltd. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health issues. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Takahashi has collaborated with esteemed colleagues such as Mitsuhito Shibasaki and Kohei Ohata. These partnerships have fostered an environment of innovation and have contributed to the advancement of pharmaceutical research.

Conclusion

Hiroyasu Takahashi's contributions to pharmaceutical chemistry through his patents and collaborations highlight his commitment to improving healthcare. His innovative work continues to pave the way for new treatments and therapies that can benefit patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…